Fujifilm Reports Increase In FY21 Profit, Projects Growth In FY22 Revenue

Fujifilm Holdings (FUJIF.PK,FUJIY.PK) Wednesday reported full-year net profit of 181.21 billion yen, up from 124.99 billion yen last year. On a per-share basis, net income attributable to the company was 451.75 yen, up from 305.22 yen a year ago.

Revenue for the period declined slightly to 2.192 trillion from 2.315 trillion a year ago.

Looking ahead to the fiscal year 2022, the company expects a 28.3 percent decline in net income attributable to Fujifilm holdings to 130 billion yen, compared to 181.2 billion yen last year.

The company now projects 11.3 percent growth in revenue to 2.440 trillion for the fiscal year ending March 31, 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT